Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Spiny mice can regenerate tissues instead of forming scars.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

JAK inhibitors offer new hope for treating severe alopecia areata.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Etanercept effectively treated a severe skin condition when other treatments failed.

Angelica sinensis helps repair and regenerate the thymus in mice.

Human-hair keratin artificial tendons are biocompatible and degrade well in rabbits.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

A group has developed therapies that show promise for treating cancer and various other conditions.

The role of γδT-cells in causing alopecia areata remains unclear.

Human-robot interaction becomes simpler as robots achieve full autonomy in surgery.

Activating Kras in mouse skin causes excess skin and hair loss.

AI-assisted surgical robots improve surgery precision and safety.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Anwuligan may help treat hair loss by promoting hair growth.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Trichohyalin may trigger the immune response causing alopecia areata.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

The new microneedle system promotes hair growth by improving the hair follicle environment.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.